Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography

Lung cancer is currently the leading cause of cancer death in both developing and developed countries. Given that lung cancer has poor prognosis in later stages, it is essential to achieve an early diagnosis to maximize patients’ overall survival. Non-small cell lung cancer (NSCLC) is the most commo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kan, Chin Fung Kelvin, Unis, Graham D., Li, Luke Z., Gunn, Susan, Li, Li, Soyer, H. Peter, Stark, Mitchell S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099172/
https://www.ncbi.nlm.nih.gov/pubmed/33968710
http://dx.doi.org/10.3389/fonc.2021.555331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099172/
https://www.ncbi.nlm.nih.gov/pubmed/33968710
http://dx.doi.org/10.3389/fonc.2021.555331

Ejemplares similares